Literature DB >> 23180025

Irreversible electroporation: an in vivo study with dorsal skin fold chamber.

Zhenpeng Qin1, Jing Jiang, Gary Long, Bruce Lindgren, John C Bischof.   

Abstract

Irreversible electroporation (IRE) has been proposed to destroy large amounts of tumorous tissue and shows advantages over thermal therapies. Unfortunately, carefully constructed studies assessing impact in in vivo tumor systems and a direct comparison of IRE with thermal therapy are lacking. In this study, we investigate the effect of IRE in a human prostate cancer (LNCaP) grown in a thin, essentially two-dimensional, dorsal skin fold chamber system. Detailed experimental characterizations of the electrical and thermal responses of the tissue were performed yielding the first thermal response measurement in vivo of its kind that we are aware of. The interaction and coupling of electrical and thermal responses were further discussed. The threshold of the tumor injury was determined for human prostate tumor model, and the threshold value (600-1300 V cm(-1)) is dependent on the IRE parameters including pulse duration and pulse number. This dependence was explained in the context of tissue electrical conductivity change during IRE. Further, the thermal injury was found not to be a dominant factor in IRE with our system, which is in agreement with previous numerical studies. Finally, it appears that the local electrical heterogeneity of the tumor tissue reduces the effectiveness of IRE in some sections of the tumor (leading to live tumor patches).

Entities:  

Mesh:

Year:  2012        PMID: 23180025     DOI: 10.1007/s10439-012-0686-1

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  18 in total

1.  Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Yoshiyuki Kobayashi; Kazuhiro Saito; Hirohito Takeuchi; Saori Ogawa; Mayumi Ando; Takatomo Sano; Toshifumi Mori; Yoshihiro Furuichi; Ikuo Nakamura
Journal:  Jpn J Radiol       Date:  2015-06-02       Impact factor: 2.374

Review 2.  [Irreversible electroporation. Current value for focal treatment of prostate cancer].

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

3.  Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.

Authors:  H J Scheffer; K Nielsen; A A J M van Tilborg; J M Vieveen; R A Bouwman; G Kazemier; H W M Niessen; S Meijer; C van Kuijk; M P van den Tol; M R Meijerink
Journal:  Eur Radiol       Date:  2014-06-18       Impact factor: 5.315

Review 4.  The state of irreversible electroporation in interventional oncology.

Authors:  Mikhail Silk; David Tahour; Govindarajan Srimathveeravalli; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 5.  Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  World J Urol       Date:  2016-05-04       Impact factor: 4.226

6.  Feasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling.

Authors:  Thomas Wimmer; Govindarajan Srimathveeravalli; Mikhail Silk; Sebastien Monette; Narendra Gutta; Majid Maybody; Joseph P Erinjery; Jonathan A Coleman; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Technol Cancer Res Treat       Date:  2015-10-06

7.  Percutaneous Irreversible Electroporation for Treatment of Small Hepatocellular Carcinoma Invisible on Unenhanced CT: A Novel Combined Strategy with Prior Transarterial Tumor Marking.

Authors:  Feng Pan; Thuy D Do; Dominik F Vollherbst; Philippe L Pereira; Götz M Richter; Michael Faerber; Karl H Weiss; Arianeb Mehrabi; Hans U Kauczor; Christof M Sommer
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

8.  Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing.

Authors:  Samuel M Hanson; Bruce Forsyth; Chun Wang
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

9.  Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).

Authors:  Bor Kos; Peter Voigt; Damijan Miklavcic; Michael Moche
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

10.  A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue.

Authors:  Paulo A Garcia; Rafael V Davalos; Damijan Miklavcic
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.